Mylab acquires majority stake in Point-of-Care start-up, Sanskritech - the developer of Swayam
70+ tests for diseases
and telemedicine facility
Investment will be used to develop affordable Point of Care labs with 70+ tests
Mylab will start deploying systems with its lab partners from Nov 2021
Pune | Sep 2021 – Mylab Discovery Solutions, India’s leading biotech company, has announced acquisition of majority stake in Sanskritech – the developer of Swayam, which is India’s first most advanced Point of Care Testing system with over 90 test parameters and telemedicine facility. The investment is in line with Mylab’s vision of making diagnostics accessible to all. Mylab will establish point of care (POC) testing labs at doctor offices, nursing homes, community health centers, airports, etc. through lab partners to enable patients get test results faster, at a lower cost and without the need to wait for hours.
Swayam is portable diagnostic and tele-medicine point-of-care system which can be used to create a small lab anywhere. This will help people to test for a wide range of diseases within a few minutes. Patients can also consult doctors using telemedicine facility and start treatment instantly. Mylab will use its expertise in diagnostic solutions development, biosensors, robotics, liquid handling to further expand test menu and embed Artificial Intelligence which will facilitate faster reporting and consultation with doctor an even better experience.
“During the second wave, we saw overburdening of our testing systems. It became evident that decentralized testing would significantly improve access and turnaround times. Point-of-Care labs will be a game-changer in the diagnostics space. This acquisition will enable us to further strengthen our efforts to make point-of-care testing available everywhere in India including a remote village.” said Hasmukh Rawal, Managing Director, Mylab.
Commenting on the acquisition, Pritam Kumawat, Founder of Sanskritech said, “Through our IoT based POC system, Swayam, we have been striving to leverage technology to create an easy access to basic healthcare at an affordable cost. We look forward to working closely with Mylab to make point-of-care testing available across the country.”
As part of the deal, Mylab will acquire a majority stake in Sanskritech in all-cash deal. Sansktitech team will continue to operate as a separate entity under the aegis of Mylab.
Mylab plans to establish more than 1000 POC systems in the next two years and start deployment of these systems with lab partners as early as November 2021. These POC systems will offer a comprehensive range of tests including:
Blood tests – Blood Glucose, Hemoglobin, Lipid assay, Cardiac Marker assay, Full blood work, Liver function test, Hormonal assay, Thyroid, etc.
Disease tests – Hepatitis B (HBV), Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV), Malaria, Dengue, Chikungunya, Tuberculosis, Respiratory Diseases, Metabolic Diseases, Skin diseases, etc.
Other – ENT, Skin Test, Vision Test, ECG 12 lead, Alcohol Detection, etc.
Basic – Height, Weight, BMI, Blood Pressure, Temperature, etc.
About Mylab Discovery Solutions
We are an Indian biotech firm focused on developing & commercializing Molecular, Serological, Immunology testing solutions and equipment for applications in clinical diagnostics, drug discovery, biomedical research, agrigenomics, animal and food safety.
We are a new age innovation enterprise committed to deliver path breaking technology to enrich human lives in more ways than one. Combining various disciplines of engineering with ethos of human values, traditions and principles, Sanskritech weaves technology into culture and lifestyle to redefine standards of living. In a world where technology finds itself gaining prominence as an integral part of human ecosystem, Sanskritech has taken the lead to pioneer 3rd millennium technology solutions that ushers an era of renaissance for a more progressively human society.